Impedimed (ASX:IPD) FCF Margin %: -119.58% (As of Dec. 2025)


What is Impedimed FCF Margin %?

Impedimed ASX:IPD FCF Margin % is -119.58% as of Dec. 2025. The stock has 6 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Impedimed ranks worse than 85.28% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Impedimed's Free Cash Flow for the six months ended in Dec. 2025 was A$-8.99 Mil. Impedimed's Revenue for the six months ended in Dec. 2025 was A$7.52 Mil. Therefore, Impedimed's FCF Margin % for the quarter that ended in Dec. 2025 was -119.58%.

As of today, Impedimed's current FCF Yield % is -91.57%.

The historical rank and industry rank for Impedimed's FCF Margin % or its related term are showing as below:

ASX:IPD' s FCF Margin % Range Over the Past 10 Years
Min: -532.26   Med: -294.82   Max: -117.47
Current: -117.47

During the past 13 years, the highest FCF Margin % of Impedimed was -117.47%. The lowest was -532.26%. And the median was -294.82%.

ASX:IPD's FCF Margin % is ranked worse than
85.28% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.03 vs ASX:IPD: -117.47

Impedimed FCF Margin % Related Terms

Impedimed FCF Margin % Historical Data

* Premium members only.

The historical data trend for Impedimed's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Impedimed FCF Margin % Chart

Impedimed Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -188.14 -199.00 -214.17 -207.84 -122.87

Impedimed Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -179.63 -232.63 -131.63 -115.12 -119.58

ASX:IPD vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, Impedimed's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Impedimed FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Impedimed's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Impedimed's FCF Margin % falls into.


Impedimed FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Impedimed's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-15.634/12.724
=-122.87 %

Impedimed's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-8.988/7.516
=-119.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -119.58% mean?
Impedimed (ASX:IPD) has a FCF Margin % of -119.58% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Impedimed and its competitors. According to the industry distribution chart, Impedimed ranks #695 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 85.3%.
Is Impedimed's FCF Margin % too high?
Impedimed's current FCF Margin % is -119.58%. Based on the distribution chart, Impedimed ranks #695 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Impedimed's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Impedimed ranks #695 out of 815 companies for FCF Margin %. This places Impedimed in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Impedimed and its competitors. Impedimed's current FCF Margin % is -119.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Impedimed stock overvalued right now?
Based on GuruFocus' analysis, Impedimed (ASX:IPD) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.08, compared to a current price of A$0.01 — trading 93.8% below its estimated fair value. The current FCF Margin % is -119.58%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Impedimed (ASX:IPD), the current FCF Margin % is -119.58% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Impedimed Business Description

Other Exchanges IPDQF:USA
Address 5900 Pasteur Court, Suite 125, Carlsbad, CA, USA, 92008
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognises revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.